Neuroimmune phenotypes in brain aneurysms and neurodegenerative diseases
- 1Department of Neurology, Detroit Medical Center, Wayne State University School of Medicine , , ,
- 2Division of Neuropathology, University of California, Los Angeles , , ,
Abstract
Aneurysmal subarachnoid hemorrhage is a devastating neurological disease that occurs downstream of abnormal dilation of cerebral vessels and weakening of the vessel wall due to underlying inflammation. Vascular endothelial inflammation has been identified as a critical driver of aneurysm growth and progression, with numerous immune cell populations proposed to have a role in this process. The innate immune cells that partake in the process of aneurysm growth, primarily macrophages, can adopt pro-inflammatory or anti-inflammatory phenotypes. A recent line of work implicates an imbalance in macrophage phenotypes as a critical feature in the progression of cerebral aneurysmal disease. An imbalance in immune cell states is also observed in neurodegenerative processes, where the inflammatory phenotypes of microglia and astrocytes appear to be involved in disease progression. Understanding cerebral aneurysms and neurodegeneration as processes that involve inflammatory imbalances may provide a window for future research and identification of therapeutic targets, where modulating immune phenotypes has the potential to reduce both aneurysm rupture risk and neurodegenerative progression. Further, advances in treatments for one disease could be cautiously applied in preclinical models for the other.
Related
- Editorial: Glucose metabolism in brain and neurodegenerative diseases: multifactorial effects
- Brain-computer interfaces for neurodegenerative diseases: A comprehensive review of closed-loop systems from diagnosis to neural rehabilitation
- Brain aging and neurodegenerative diseases: physiological insights from anti-aging protein Klotho
- Diagnostic Value of Large Language Model-Extracted Gross Brain Findings in Neurodegenerative Diseases
- Mapping polygenic risk scores to brain cells: insights for neurodegenerative diseases
BibTeX
@article{lauzier2026neuroimmune,
title = {{Neuroimmune phenotypes in brain aneurysms and neurodegenerative diseases}},
author = {Francis J. Lauzier and David C. Lauzier},
journal = {Frontiers in neuroscience},
year = {2026},
month = sep,
doi = {10.3389/fnins.2026.1916561},
url = {https://europepmc.org/article/PMC/PMC13662010},
note = {CC BY},
}
RIS
TY - JOUR
TI - Neuroimmune phenotypes in brain aneurysms and neurodegenerative diseases
AU - Francis J. Lauzier
AU - David C. Lauzier
PY - 2026
DA - 2026/09/30
JO - Frontiers in neuroscience
DO - 10.3389/fnins.2026.1916561
UR - https://europepmc.org/article/PMC/PMC13662010
AB - Aneurysmal subarachnoid hemorrhage is a devastating neurological disease that occurs downstream of abnormal dilation of cerebral vessels and weakening of the vessel wall due to underlying inflammation. Vascular endothelial inflammation has been identified as a critical driver of aneurysm growth and progression, with numerous immune cell populations proposed to have a role in this process. The innate immune cells that partake in the process of aneurysm growth, primarily macrophages, can adopt pro-inflammatory or anti-inflammatory phenotypes. A recent line of work implicates an imbalance in macrophage phenotypes as a critical feature in the progression of cerebral aneurysmal disease. An imbalance in immune cell states is also observed in neurodegenerative processes, where the inflammatory phenotypes of microglia and astrocytes appear to be involved in disease progression. Understanding cerebral aneurysms and neurodegeneration as processes that involve inflammatory imbalances may provide a window for future research and identification of therapeutic targets, where modulating immune phenotypes has the potential to reduce both aneurysm rupture risk and neurodegenerative progression. Further, advances in treatments for one disease could be cautiously applied in preclinical models for the other.
SN - 1662-4548
SN - 1662-453X
ER -